Very small initial study (N=16), but this is exciting initial outcome. Keep your eyes on this approach over the next 5 years to see where it goes.
medpagetoday.com/hematology...
peace,
Missy
Very small initial study (N=16), but this is exciting initial outcome. Keep your eyes on this approach over the next 5 years to see where it goes.
medpagetoday.com/hematology...
peace,
Missy
I am really hopeful that this will be an answer for immunotherapy non responders. We need that! Keeping all my fingers and toes crossed.